Prostate cancer decisions — 2025

The veteran's appeal requests for service connection for hearing loss, prostate cancer, PTSD, and obstructive sleep apnea were dismissed as the appeals were not timely filed.

The Board remands the claims for service connection for prostate cancer, hypertension, and diabetes mellitus type II due to duty-to-assist errors and a need for additional development of evidence related to in-service chemical exposures.

The Board denied the veteran's claims for increased ratings for bilateral hearing loss and tinnitus, as well as service connection for prostate cancer.

The Veteran was granted a total disability rating due to individual unemployability (TDIU) for the period from January 7, 2016, to January 31, 2022, based on his service-connected prostatic adenocarcinoma.

The Board granted service connection for prostate cancer, finding that it is at least as likely as not related to the Veteran's toxic exposure risk activity in service.

The Board granted an increased rating of 40 percent for prostate cancer from August 10, 2022 to July 26, 2023, and beginning August 14, 2023.

The Board granted service connection for tinnitus and denied a compensable rating for the residuals of tonsillectomy. The claims for left foot disability and prostate cancer were remanded.

The Board denied the claims for an earlier effective date for service connection for the cause of death and for service connection for prostate cancer, finding no evidence supporting a link between the Veteran's prostate cancer and his military service.

The Board denied an earlier effective date for the grant of service connection for the Veteran's disabilities and ancillary compensation benefits, finding that August 8, 2023, was correctly assigned as the effective date.

The Board denied a separate 100 percent rating for prostate cancer and special monthly compensation (SMC) at the housebound rate.

The Board granted service connection for the circumcision scar and remanded several other conditions, including prostate cancer, ED, suprapubic pain, voiding dysfunction, tuberculosis, sarcoidosis, and granulomatous epididymitis, due to a need for further evidence.

The Board granted service connection for the cause of the Veteran's death, finding that his service-connected disabilities contributed substantially to his death.

The Board granted earlier effective dates for service connection of various conditions, including fingers and wrists, but denied earlier effective dates for diabetic peripheral neuropathy, nephropathy, erectile dysfunction, and prostate cancer residuals.

The Board denied service connection for residuals of prostate cancer due to herbicide exposure, as there was no evidence of exposure to herbicides during the Veteran's active duty service.

The Board denied the Veteran's claims for increased ratings for his left eye disability and residuals of prostate cancer, as the evidence did not support higher ratings under the applicable criteria.

The Board remanded the case for the AOJ to gather missing medical and transportation records necessary to determine whether the Veteran's special mode transportation on December 26-27, 2024 qualifies for payment or reimbursement under 38 U.S.C. §§ 111 and 1728. The decision was necessary because critical records relating to the ambulance transportation, hospital treatment, and VA authorization/reimbursement status were absent from the claims file.

The Board granted service connection for prostate cancer, finding that it was at least as likely as not incurred in service due to exposure to water contaminants at Camp Lejeune.

The Veteran's service-connected disabilities render him unable to secure and follow a substantially gainful occupation, leading to the grant of individual unemployability (TDIU).

The Board granted an effective date of December 30, 2021 for the grant of service connection for prostate cancer, erectile dysfunction, and scars status-post robotic radical prostatectomy.

The Board granted service connection for colorectal cancer, prostate cancer, and lung cancer based on new evidence and the Veteran's exposure to contaminated Camp Lejeune water.